Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Study of PX-866 and Docetaxel in Solid Tumors

This study has been completed.
Information provided by (Responsible Party):
Cascadian Therapeutics Inc. Identifier:
First received: September 15, 2010
Last updated: May 19, 2015
Last verified: April 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2014
  Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: April 30, 2015